(422 days)
No
The summary describes a TENS device with EMG and ENG capabilities, focusing on electrical stimulation, biofeedback, and monitoring. There is no mention of AI or ML in the intended use, device description, or performance studies. The "Mentions AI, DNN, or ML" section explicitly states "Not Found".
Yes
The device is indicated for symptomatic relief and management of chronic pain, intractable pain, post-traumatic pain, biofeedback, relaxation training, and muscle re-education, which are all therapeutic uses.
Yes
The device uses surface electromyography and electroneurography for monitoring and displaying bioelectric signals, including electrical activity produced by nerves and muscles, which are diagnostic functions.
No
The device description explicitly lists hardware components such as a console, mobile floor stand, power cord, battery charger, patient remote control, and cables. It also mentions using commercially available electrodes.
Based on the provided information, the Aptiva™ v2.13U is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use clearly describes the device as a transcutaneous electrical nerve stimulator (TENS) for pain management and a system for surface electromyography (EMG) and electroneurography (ENG) for biofeedback, muscle re-education, and monitoring bioelectric signals. These are all in vivo applications, meaning they interact directly with the living body.
- Device Description: The description details components like electrodes, cables, and a console, which are consistent with a device applied to the body's surface.
- Lack of IVD Characteristics: There is no mention of analyzing samples taken from the body (like blood, urine, tissue, etc.) or performing tests outside the body to diagnose or monitor a condition.
IVD devices are specifically designed to examine specimens derived from the human body to provide information for diagnostic, monitoring, or compatibility purposes. The Aptiva™ v2.13U's function is to apply electrical stimulation to the body and measure electrical activity on the body's surface.
N/A
Intended Use / Indications for Use
The Aptiva™ v2.13U is a multifunctional transcutaneous electrical nerve stimulator (TENS) equipped with a surface electromyography and electroneurography.
Aptiva™ is indicated for symptomatic relief and management of chronic pain, intractable pain and/or as an adjunctive treatment for the management of post-traumatic pain.
The dynamic surface electromyography and electroneurography system is used for biofeedback, relaxation training, and muscle re-education as well as monitoring and display of bioelectric signals produced by muscles, stimulate peripheral nerves, and monitor and display the electrical activity produced by nerves.
Product codes (comma separated list FDA assigned to the subject device)
GZJ, HCC, IKN, JXE
Device Description
The Aptiva™ v2.13U consists of a console on a mobile floor stand, power cord, battery charger, patient remote control, cables, and Manuals (User and Application). The Aptiva™ v2.13U is provided in four functional models (Ballet, Flamenco, Hip-Hop, and Jazz). EMG features are provided in the Ballet and Hip Hop models. One version of the Ballet model (Option Etoile) includes electroneurography (ENG) functions and a printer. Aptiva™ v2.13U uses commercially available electrodes. Models designated "Light" versions do not include the full treatment databases.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Prescription Use
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Testing included in this premarket notification includes electrical safety, electromagnetic compatibility, and design verification and validation testing. No materials of the Aptiva™ v2.13U are in direct contact with treatment sites and therefore no biocompatibility testing was provided. Test results demonstrate that the Aptiva™ v2.13U fulfills the prospectively defined performance specifications.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K021755, K032994, K970249, K022405, K003433, K972487, K013399, K981405, K010269
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 882.5890 Transcutaneous electrical nerve stimulator for pain relief.
(a)
Identification. A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.(b)
Classification. Class II (performance standards).
0
510(k) Summary Lorenz Biotech S.p.A Aptiva™ v2.13U
1. SPONSOR
AUG 2 4 2007
Lorenz Biotech S.p.A. Via Statale 12, 109/B/C 41036 Medolla Italy
| Contact Person: | Mr. Riccardo Isani |
|---|---|
| Email address: | Riccardo.isani@lorenzbiotech.it |
| Date Prepared: | August 6, 2007 |
2. DEVICE NAME
| Proprietary Name: | Aptiva™ v2.13U |
|---|---|
| Common/Usual Name: | Transcutaneous nerve stimulator (TENS) |
| Biofeedback device | |
| Electromyography device (EMG) | |
| Nerve conduction velocity measurement device | |
| Classification Name: | Transcutaneous nerve stimulator (TENS) |
| Biofeedback device | |
| Electromyography device (EMG) | |
| Nerve conduction velocity measurement device |
3. PREDICATE DEVICES
| Functionality | Predicate Device |
|---|---|
| TENS | • Apex Medical Digital TENS (K021755) |
| • GEMS-HV TENS (K032994) | |
| • Bioscope SD TENS (K970249) | |
| • Promax TENS (K022405) | |
| • NeuroTrain III (K003433) | |
| Electromyography (EMG)/Biofeedback | • EMG Retrainer Dual Channel (K972487) |
| • MES-9000/EMG System (K013399) | |
| • Synergy System (K981405) | |
| Nerve conduction velocity (ENG) | Brevio (K010269) |
1
4. DEVICE DESCRIPTION
The Aptiva™ v2.13U consists of a console on a mobile floor stand, power cord, battery charger, patient remote control, cables, and Manuals (User and Application). The Aptiva™ v2.13U is provided in four functional models (Ballet, Flamenco, Hip-Hop, and Jazz). EMG features are provided in the Ballet and Hip Hop models. One version of the Ballet model (Option Etoile) includes electroneurography (ENG) functions and a printer. Aptiva™ v2.13U uses commercially available electrodes. Models designated "Light" versions do not include the full treatment databases.
5. INTENDED USE
The AptivaTM is a multifunctional transcutaneous electrical nerve stimulator (TENS) equipped with a surface electromyography and electroneurography.
AptivaTM is indicated for symptomatic relief and management of chronic pain. intractable pain and/or as an adjunctive treatment for the management of posttraumatic pain.
The dynamic surface electromyography and electroneurography system is used for biofeedback, relaxation training, and muscle re-education as well as monitoring and display of bioelectric signals produced by muscles, stimulate peripheral nerves, and monitor and display the electrical activity produced by nerves.
6. TECHNOLOGICAL CHARACTERISTICS AND SUBSTANTIAL EQUIVALENCE
The Aptiva™ v2.13U is substantially equivalent to specified predicate devices based on intended use, indications for use, operational characteristics, and fundamental technological characteristics. Detailed side-by-side comparisons of the Aptiva™ v2.13U with cited predicate devices were included in the premarket notification and associated amendments.
7. PERFORMANCE TESTING
Testing included in this premarket notification includes electrical safety, electromagnetic compatibility, and design verification and validation testing. No materials of the Aptiva™ v2.13U are in direct contact with treatment sites and therefore no biocompatibility testing was provided. Test results demonstrate that the Aptiva™ v2.13U fulfills the prospectively defined performance specifications.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is an abstract image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
AUG 2 4 2007
Lorenz Biotech S.P.A. C/O Rosina Robinson, RN, MEd, RAC Medical Device Consultants, Inc. 49 Plain Street North Attleboro, MA 02760
Re: K061828
Trade Name: Aptiva 10 v2.13 Regulation Number: 21 CFR 882.5890 Regulation Name: Transcutaneous electrical nerve stimulator for pain relief Regulatory Class: Class II Product Code: GZJ, HCC, IKN, JXE Dated: August 6, 2007 Received: August 7, 2007
Dear Ms. Robinson:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
3
Page 2 - Rosina Robinson, RN, MEd, RAC
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding postmarket surveillance. please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Mark N. Melkerson, M.S.
Mark N. Melkerson, M.S Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known): K061828
Device Name: Lorenz Biotech Aptiva™ v2.13U
Indications for Use:
The Aptiva™ v2.13U is a multifunctional transcutaneous electrical nerve stimulator (TENS) equipped with a surface electromyography and electroneurography.
Aptiva™ is indicated for symptomatic relief and management of chronic pain, intractable pain and/or as an adjunctive treatment for the management of post-traumatic pain.
The dynamic surface electromyography and electroneurography system is used for biofeedback, relaxation training, and muscle re-education as well as monitoring and display of bioelectric signals produced by muscles, stimulate peripheral nerves, and monitor and display the electrical activity produced by nerves.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
sion Sign-Off Division of General. Restorative. and Neurological Devices
510(k) Number K061828